Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-19

FDA Approved: URSODIOL — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for URSODIOL from Actavis Pharma, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • URSODIOL (ursodiol)

Snippet

SUPPL AP for URSODIOL (URSODIOL)